Back to Dashboard
ABT · Healthcare

ABBOTT LABORATORIES

USA Healthcare Filing: 2025-12-31
7
Tracked Holders
Limited info. ABBOTT LABORATORIES is not currently in our model portfolio, but 7 tracked investors hold it. We're showing what we know from their latest 13F filings.
Market cap
$172.1B
Industry
Medical Devices
Exchange
NYSE
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and…
7
Investors
1
New positions
4
Increasing
2
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Tudor Investment (Paul Tudor Jones)
Trust weight: 1.2×
New position
% of portfolio
0.1%
Position change
NEW
0.1% of Tudor Investment's portfolio
Citadel Advisors
Trust weight: 1.0×
Increased +255%
% of portfolio
0.2%
Position change
+255%
0.2% of Citadel Advisors's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Increased +3296%
% of portfolio
0.1%
Position change
+3296%
0.1% of D.E. Shaw & Co's portfolio
Bridgewater Associates (Dalio)
Trust weight: 1.3×
Increased +3%
% of portfolio
0.1%
Position change
+3%
0.1% of Bridgewater Associates's portfolio
Gotham Asset Mgmt (Greenblatt)
Trust weight: 1.1×
Increased +75%
% of portfolio
0.1%
Position change
+75%
0.1% of Gotham Asset Mgmt's portfolio
AQR Capital Management
Trust weight: 1.0×
Decreased −7%
% of portfolio
0.1%
Position change
−7%
0.1% of AQR Capital Management's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Decreased −10%
% of portfolio
0.0%
Position change
−10%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ABBOTT LABORATORIES
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ABBOTT LABORATORIES or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API